Experimental drug is helpful against c. diff, animal study finds

Share this article:
An experimental compound, which investigators say could be used as an alternative to antibiotics, has been shown to be effective in fighting Clostridium difficile in laboratory mice.

The compound mimics a natural cellular defense mechanism that neutralizes the toxins that cause c. difficile. The disease, which causes severe diarrhea, is one of the most common healthcare-acquired infections and can prove deadly in elderly nursing home residents.

In laboratory studies, conducted by investigators at University of California, Los Angeles, Case Western Reserve University, Tufts University and the Commonwealth Medical College and the University of Texas Medical Branch at Galveston, mice treated with the compound became less ill and were more likely to survive C. diff infection than untreated mice, according to the study.

"This may prove to be an alternative to antibiotics," study author Tor Savidge, M.D., told Reuters, adding that more study is needed.

The study was published in the journal Nature Medicine.

Share this article:

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...